Fuzheng	B:C0574031
Qingjie	I:C0574031
Granules	I:C0574031
Inhibit	O
Growth	O
of	O
Hepatoma	O
Cells	O
via	O
Inducing	O
Mitochondria	O
-	O
Mediated	O
Apoptosis	O
and	O
Enhancing	O
Immune	O
Function	I:C1817756
.	O

Fuzheng	O
Qingjie	I:C0574031
Granules	I:C0574031
Inhibit	O
Growth	B:C0220844
of	O
Hepatoma	O
Cells	O
via	O
Inducing	O
Mitochondria	O
-	O
Mediated	O
Apoptosis	O
and	O
Enhancing	O
Immune	O
Function	I:C1817756
.	O

Fuzheng	O
Qingjie	I:C0574031
Granules	I:C0574031
Inhibit	O
Growth	O
of	O
Hepatoma	O
Cells	O
via	O
Inducing	O
Mitochondria	B:C0026237
-	O
Mediated	O
Apoptosis	O
and	O
Enhancing	O
Immune	O
Function	I:C1817756
.	O

Fuzheng	O
Qingjie	I:C0574031
Granules	I:C0574031
Inhibit	O
Growth	O
of	O
Hepatoma	O
Cells	O
via	O
Inducing	O
Mitochondria	O
-	O
Mediated	O
Apoptosis	B:C0162638
and	O
Enhancing	O
Immune	O
Function	I:C1817756
.	O

Fuzheng	O
Qingjie	I:C0574031
Granules	I:C0574031
Inhibit	O
Growth	O
of	O
Hepatoma	O
Cells	O
via	O
Inducing	O
Mitochondria	O
-	O
Mediated	O
Apoptosis	O
and	O
Enhancing	O
Immune	B:C1817756
Function	I:C1817756
.	O

Fuzheng	B:C0574031
Qingjie	I:C0574031
(	O
FZQJ	I:C0574031
)	I:C0574031
granules	I:C0574031
,	O
a	O
compound	O
Chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
for	O
alimentary	O
tract	I:C0017189
cancers	O
.	O

Fuzheng	O
Qingjie	I:C0574031
(	B:C0574031
FZQJ	I:C0574031
)	I:C0574031
granules	I:C0574031
,	O
a	O
compound	O
Chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
for	O
alimentary	O
tract	I:C0017189
cancers	O
.	O

Fuzheng	O
Qingjie	I:C0574031
(	O
FZQJ	I:C0574031
)	I:C0574031
granules	I:C0574031
,	O
a	O
compound	B:C1706082
Chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
for	O
alimentary	O
tract	I:C0017189
cancers	O
.	O

Fuzheng	O
Qingjie	I:C0574031
(	O
FZQJ	I:C0574031
)	I:C0574031
granules	I:C0574031
,	O
a	O
compound	O
Chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	B:C0677850
therapy	I:C0677850
for	O
alimentary	O
tract	I:C0017189
cancers	O
.	O

Fuzheng	O
Qingjie	I:C0574031
(	O
FZQJ	I:C0574031
)	I:C0574031
granules	I:C0574031
,	O
a	O
compound	O
Chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
for	O
alimentary	B:C0017189
tract	I:C0017189
cancers	O
.	O

Fuzheng	O
Qingjie	I:C0574031
(	O
FZQJ	I:C0574031
)	I:C0574031
granules	I:C0574031
,	O
a	O
compound	O
Chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
for	O
alimentary	O
tract	I:C0017189
cancers	B:C0006826
.	O

However	O
,	O
the	O
underlying	O
anticancer	B:C0243095
mechanisms	O
are	O
still	O
not	O
well	O
understood	O
.	O

In	O
the	O
present	O
study	B:C2603343
,	O
HepG2	O
cells	I:C2717940
were	O
treated	O
with	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
.	O

In	O
the	O
present	O
study	O
,	O
HepG2	B:C2717940
cells	I:C2717940
were	O
treated	O
with	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
.	O

In	O
the	O
present	O
study	O
,	O
HepG2	O
cells	I:C2717940
were	O
treated	O
with	O
Fuzheng	B:C0574031
Qingjie	I:C0574031
-	O
containing	O
serum	O
.	O

In	O
the	O
present	O
study	O
,	O
HepG2	O
cells	I:C2717940
were	O
treated	O
with	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	B:C0229671
.	O

Cell	B:C0596290
proliferation	I:C0596290
was	O
evaluated	O
using	O
MTT	O
assay	I:C2986858
.	O

Cell	O
proliferation	I:C0596290
was	O
evaluated	B:C0220825
using	O
MTT	O
assay	I:C2986858
.	O

Cell	O
proliferation	I:C0596290
was	O
evaluated	O
using	O
MTT	B:C2986858
assay	I:C2986858
.	O

Apoptosis	B:C0162638
was	O
analyzed	O
using	O
a	O
flow	O
cytometer	I:C0180279
.	O

Apoptosis	O
was	O
analyzed	B:C0936012
using	O
a	O
flow	O
cytometer	I:C0180279
.	O

Apoptosis	O
was	O
analyzed	O
using	O
a	O
flow	B:C0180279
cytometer	I:C0180279
.	O

Cell	O
ultrastructure	O
was	O
observed	O
under	O
a	O
transmission	B:C0262880
electron	I:C0262880
microscope	I:C0262880
.	O

The	O
mitochondrial	B:C1720920
membrane	I:C1720920
potential	I:C1720920
(	O
Δψ	O
)	O
was	O
examined	O
with	O
JC	O
-	I:C0013343
1	I:C0013343
dye	I:C0013343
.	O

The	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
Δψ	B:C1720920
)	O
was	O
examined	O
with	O
JC	O
-	I:C0013343
1	I:C0013343
dye	I:C0013343
.	O

The	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
Δψ	O
)	O
was	O
examined	B:C0332128
with	O
JC	O
-	I:C0013343
1	I:C0013343
dye	I:C0013343
.	O

The	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
Δψ	O
)	O
was	O
examined	O
with	O
JC	B:C0013343
-	I:C0013343
1	I:C0013343
dye	I:C0013343
.	O

In	O
H22	B:C1512411
tumor	I:C1512411
-	I:C1512411
bearing	I:C1512411
mice	I:C1512411
,	O
CD4	O
(	I:C0039215
+	I:C0039215
)	I:C0039215

In	O
H22	O
tumor	I:C1512411
-	I:C1512411
bearing	I:C1512411
mice	I:C1512411
,	O
CD4	B:C0039215
(	I:C0039215
+	I:C0039215
)	I:C0039215

T	I:C0039215
cells	I:C0039215
,	O
CD8	B:C0242629
(+	I:C0242629
)	I:C0242629

T	I:C0242629
cells	I:C0242629
,	O
CD3	B:C1267816
(+	I:C1267816
)	I:C1267816

T	I:C1267816
cells	I:C1267816
,	O
and	O
natural	B:C0022688
killer	I:C0022688
cells	I:C0022688
(	O
natural	O
killer	I:C0022688
cells	I:C0022688
)	O
in	O
peripheral	O
blood	I:C0229664
were	O
evaluated	O
cytometrically	O
.	O

T	I:C1267816
cells	I:C1267816
,	O
and	O
natural	O
killer	I:C0022688
cells	I:C0022688
(	O
natural	B:C0022688
killer	I:C0022688
cells	I:C0022688
)	O
in	O
peripheral	O
blood	I:C0229664
were	O
evaluated	O
cytometrically	O
.	O

T	I:C1267816
cells	I:C1267816
,	O
and	O
natural	O
killer	I:C0022688
cells	I:C0022688
(	O
natural	O
killer	I:C0022688
cells	I:C0022688
)	O
in	O
peripheral	B:C0229664
blood	I:C0229664
were	O
evaluated	O
cytometrically	O
.	O

T	I:C1267816
cells	I:C1267816
,	O
and	O
natural	O
killer	I:C0022688
cells	I:C0022688
(	O
natural	O
killer	I:C0022688
cells	I:C0022688
)	O
in	O
peripheral	O
blood	I:C0229664
were	O
evaluated	O
cytometrically	B:C0180279
.	O

Interleukin	B:C0021756
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
TNF	I:C0041368
)	I:C0041368
-	I:C0041368
α	I:C0041368
levels	O
were	O
measured	O
using	O
radioimmunoassay	O
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
and	O
tumor	B:C0041368
necrosis	I:C0041368
factor	I:C0041368
(	O
TNF	I:C0041368
)	I:C0041368
-	I:C0041368
α	I:C0041368
levels	O
were	O
measured	O
using	O
radioimmunoassay	O
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	B:C0041368
TNF	I:C0041368
)	I:C0041368
-	I:C0041368
α	I:C0041368
levels	O
were	O
measured	O
using	O
radioimmunoassay	O
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
TNF	I:C0041368
)	I:C0041368
-	I:C0041368
α	I:C0041368
levels	O
were	O
measured	O
using	O
radioimmunoassay	B:C0034580
.	O

The	O
mRNA	B:C0035696
levels	O
of	O
Bax	O
and	O
Bcl	O
-	I:C0376515
2	I:C0376515
were	O
examined	O
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
.	O

The	O
mRNA	O
levels	O
of	O
Bax	B:C0812198
and	O
Bcl	O
-	I:C0376515
2	I:C0376515
were	O
examined	O
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
.	O

The	O
mRNA	O
levels	O
of	O
Bax	O
and	O
Bcl	B:C0376515
-	I:C0376515
2	I:C0376515
were	O
examined	O
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
.	O

The	O
mRNA	O
levels	O
of	O
Bax	O
and	O
Bcl	O
-	I:C0376515
2	I:C0376515
were	O
examined	B:C0332128
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
.	O

The	O
mRNA	O
levels	O
of	O
Bax	O
and	O
Bcl	O
-	I:C0376515
2	I:C0376515
were	O
examined	O
by	O
reverse	B:C0599161
transcription	I:C0599161
-	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
.	O

The	O
protein	B:C0033684
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	B:C0219474
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	B:C0210955
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	B:C0010749
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	B:C0291573
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	B:C0910167
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	B:C0032405
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	B:C0108800
were	O
examined	O
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	B:C0332128
by	O
Western	O
blotting	I:C0005863
.	O

The	O
protein	O
levels	O
of	O
Bax	O
,	O
Bcl	O
-	I:C0210955
2	I:C0210955
,	O
cytochrome	O
C	I:C0010749
,	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
PARP	O
,	O
and	O
CD69	O
were	O
examined	O
by	O
Western	B:C0005863
blotting	I:C0005863
.	O

The	O
apoptotic	O
cells	B:C0007634
in	O
tissues	O
were	O
observed	O
using	O
TUNEL	O
method	O
.	O

The	O
apoptotic	O
cells	O
in	O
tissues	B:C0040300
were	O
observed	O
using	O
TUNEL	O
method	O
.	O

Alanine	B:C0001899
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	B:C0001899
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	B:C0004002
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	B:C0004002
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	B:C0600137
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	B:C0600137
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	B:C0010294
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	B:C0010294
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	B:C0442726
by	O
an	O
automatic	O
biochemical	O
analyzer	O
.	O

Alanine	O
transaminase	I:C0001899
(	O
Alanine	O
transaminase	I:C0001899
)	O
,	O
aspartate	O
transaminase	I:C0004002
(	O
aspartate	O
transaminase	I:C0004002
)	O
,	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
(	O
blood	O
urea	I:C0600137
nitrogen	I:C0600137
)	O
,	O
and	O
creatinine	O
(	O
creatinine	O
)	O
were	O
detected	O
by	O
an	O
automatic	O
biochemical	O
analyzer	B:C0179038
.	O

The	O
results	O
showed	O
that	O
Fuzheng	B:C0574031
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	B:C0229671
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	B:C0596290
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	B:C2717940
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	B:C2717940
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	B:C0162638
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	B:C1720920
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	B:C0936012
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	B:C0475358
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	B:C0574031
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	B:C0162638
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	B:C0013081
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	B:C0210955
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	B:C0041904
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	B:C0219474
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	B:C0010749
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	B:C0014429
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	B:C0291573
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	B:C0910167
,	O
and	O
cleavage	O
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	B:C0597304
of	O
PARP	O
.	O

The	O
results	O
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
HepG2	O
cells	I:C2717940
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manners	O
,	O
induced	O
HepG2	O
cell	I:C2717940
apoptosis	O
and	O
caused	O
a	O
decrease	O
of	O
Δψ.	O
Analysis	O
of	O
tumor	O
tissue	I:C0475358
showed	O
that	O
Fuzheng	O
Qingjie	I:C0574031
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
Bcl	O
-	I:C0210955
2	I:C0210955
and	O
upregulation	O
of	O
Bax	O
,	O
release	O
of	O
cytochrome	O
c	I:C0010749
,	O
activation	O
of	O
caspase	O
3	I:C0291573
and	O
9	O
,	O
and	O
cleavage	O
of	O
PARP	B:C0032405
.	O

In	O
addition	O
,	O
Fuzheng	B:C0574031
Qingjie	I:C0574031
increased	O
the	O
percentages	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215

In	O
addition	O
,	O
Fuzheng	O
Qingjie	I:C0574031
increased	O
the	O
percentages	O
of	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215

T	I:C0039215
and	O
NK	B:C0022688
cells	I:C0022688
,	O
the	O
ratio	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
/	O
CD8	O
(+)	I:C0242629

T	I:C0039215
and	O
NK	O
cells	I:C0022688
,	O
the	O
ratio	O
of	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215
/	O
CD8	O
(+)	I:C0242629

T	I:C0039215
and	O
NK	O
cells	I:C0022688
,	O
the	O
ratio	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
/	O
CD8	B:C0242629
(+)	I:C0242629

T	I:C0242629
cells	I:C0242629
as	O
well	O
as	O
the	O
levels	O
of	O
serum	B:C0229671
TNF	O
-α.	I:C0041368

T	I:C0242629
cells	I:C0242629
as	O
well	O
as	O
the	O
levels	O
of	O
serum	O
TNF	B:C0041368
-α.	I:C0041368

Fuzheng	B:C0574031
Qingjie	I:C0574031
also	O
increased	O
CD69	O
expression	O
in	O
tumor	O
tissue	I:C0475358
.	O

Fuzheng	O
Qingjie	I:C0574031
also	O
increased	O
CD69	B:C0108800
expression	O
in	O
tumor	O
tissue	I:C0475358
.	O

Fuzheng	O
Qingjie	I:C0574031
also	O
increased	O
CD69	O
expression	B:C1171362
in	O
tumor	O
tissue	I:C0475358
.	O

Fuzheng	O
Qingjie	I:C0574031
also	O
increased	O
CD69	O
expression	O
in	O
tumor	B:C0475358
tissue	I:C0475358
.	O

No	B:C0243095
hepatorenal	I:C0243095
toxicity	I:C0243095
was	O
observed	O
in	O
H22	O
tumor	I:C1512411
-	I:C1512411
bearing	I:C1512411
mice	I:C1512411
.	O

No	O
hepatorenal	I:C0243095
toxicity	I:C0243095
was	O
observed	O
in	O
H22	B:C1512411
tumor	I:C1512411
-	I:C1512411
bearing	I:C1512411
mice	I:C1512411
.	O

These	O
results	O
indicated	B:C1444656
that	O
Fuzheng	O
Qingjie	I:C0574031
could	O
inhibit	O
the	O
growth	O
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	O
function	I:C1817756
and	O
inducing	O
mitochondria	O
mediated	O
apoptosis	O
.	O

These	O
results	O
indicated	O
that	O
Fuzheng	B:C0574031
Qingjie	I:C0574031
could	O
inhibit	O
the	O
growth	O
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	O
function	I:C1817756
and	O
inducing	O
mitochondria	O
mediated	O
apoptosis	O
.	O

These	O
results	O
indicated	O
that	O
Fuzheng	O
Qingjie	I:C0574031
could	O
inhibit	O
the	O
growth	B:C0220844
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	O
function	I:C1817756
and	O
inducing	O
mitochondria	O
mediated	O
apoptosis	O
.	O

These	O
results	O
indicated	O
that	O
Fuzheng	O
Qingjie	I:C0574031
could	O
inhibit	O
the	O
growth	O
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	B:C1817756
function	I:C1817756
and	O
inducing	O
mitochondria	O
mediated	O
apoptosis	O
.	O

These	O
results	O
indicated	O
that	O
Fuzheng	O
Qingjie	I:C0574031
could	O
inhibit	O
the	O
growth	O
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	O
function	I:C1817756
and	O
inducing	O
mitochondria	B:C0026237
mediated	O
apoptosis	O
.	O

These	O
results	O
indicated	O
that	O
Fuzheng	O
Qingjie	I:C0574031
could	O
inhibit	O
the	O
growth	O
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	O
function	I:C1817756
and	O
inducing	O
mitochondria	O
mediated	O
apoptosis	B:C0162638
.	O

